Currently, oral medications like Truvada, part of a regimen called PrEP ... its high cost of $40,000 per person annually is a barrier. In October, Indian pharmaceutical companies, including ...

Indian pharmaceutical giants ... These trials demonstrated that twice-yearly lenacapavir outperformed the daily oral Truvada in reducing HIV incidence. PURPOSE 1 involved cisgender women in ...

What Truvada is, is a single pill that’s a combination of two antiretroviral drugs that have a long history of being used as part of a broader combination of therapy for the actual treatment of ...

Gilead’s HIV blockbuster Truvada looks set to face generic competition in the US next year, a year earlier than expected, putting the bulk of the product’s $3 billion annual sales at risk.